Tandem Mass Spectrometry for Protein Sequencing
Tandem mass spectrometry for protein sequencing integrates liquid chromatography and multi-stage mass spectrometry to facilitate a detailed analysis of complex protein mixtures through precise sample fragmentation. Proteins, as the primary agents of biological functions, necessitate comprehensive analysis due to their diverse and complex functional roles. Tandem mass spectrometry for protein sequencing enables rapid identification and quantification of proteins in complex biological samples. Researchers can determine the primary structure of unknown proteins-the amino acid sequence-helping to elucidate protein functions, interactions, and roles in various biological processes. This is particularly valuable in disease research, where many conditions are linked to specific protein expression anomalies or mutations. By accurately sequencing proteins and identifying post-translational modifications, tandem mass spectrometry for protein sequencing aids in discovering potential disease markers and therapeutic targets. It is also pivotal in antibody drug development, vaccine creation, and biotechnological applications. In both fundamental and applied research, this technique uncovers the intricate networks and dynamic changes of proteins.
Mass spectrometry's core capability lies in decomposing proteins into smaller peptides and measuring their mass-to-charge ratios (m/z). The MS/MS process typically involves two stages: initial separation of complex protein mixtures using techniques like liquid chromatography, and subsequent enzymatic or chemical cleavage into peptide fragments. These fragments are then further analyzed to reconstruct the complete protein sequence. Advanced software automates the identification and alignment of amino acid sequences through mass spectrometry data interpretation.
Despite its strengths, tandem mass spectrometry for protein sequencing has limitations, such as challenges in detecting low-abundance proteins in complex samples, where signals may be obscured by more abundant proteins. Sample preparation can introduce contaminants and noise, further complicating low-abundance protein detection. Achieving complete protein coverage is difficult due to incomplete proteolysis, which can leave some regions unanalyzed. Moreover, reliance on database searches for matching experimental data with theoretical peptides complicates the identification of novel or unannotated proteins. The complexity of protein mixtures can influence ionization efficiency, impacting signal strength or loss. Data processing and interpretation require specialized expertise, and even with automated software, analysis remains time-intensive with potential for errors.
MtoZ Biolabs has substantial experience in mass spectrometry-based sequencing services, staffed by seasoned proteomics experts employing cutting-edge technology and data analysis platforms to deliver precise and reliable protein analyses. Whether for unknown protein identification or comprehensive sample analysis, we offer tailored solutions to meet client needs, ensuring exceptional technical support and service in advancing research initiatives.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
